Evidence map›Paper›PMID 35904997›Full record

SynthesisStem cells (Dayton, Ohio)2022

An Updated View of the Roles of p53 in Embryonic Stem Cells.

Gamze Ayaz, Hualong Yan, Navdeep Malik, Jing Huang

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Stem cells (Dayton, Ohio), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Genes as Genome Stabilizers in Pluripotent Stem Cells.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Article
  10. Skin Development and Disease: A Molecular Perspective.Current issues in molecular biology · 2024
    Review
  11. Article
  12. Article
  13. Osmotic Pressure and Its Biological Implications.International journal of molecular sciences · 2024
    Review
  14. Characterization of p53/p63/p73 and Myc expressions during embryogenesis of the sea urchin.Developmental dynamics : an official publication of the American Association of Anatomists · 2024
    Article
  15. Article
  16. Article
  17. MutantCancers · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gamze AyazCancer and Stem Cell Epigenetics, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-1553-2558
Hualong YanCancer and Stem Cell Epigenetics, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Navdeep MalikCancer and Stem Cell Epigenetics, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jing HuangCancer and Stem Cell Epigenetics, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
National Institutes of Health · US

Funding

Vulnerabilities in osteosarcoma and breast cancerZIABC011504 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUANG, JING · 2013 to 2025
$13.3M
The roles of p53 in embryonic stem cellsZIABC011158 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUANG, JING · 2009 to 2023
$8.4M
Intramural NIH HHS ZIA BC011504NCI NIH HHS 1ZIABC011158-12
6 · The paper itself

Abstract

The TP53 gene is unarguably one of the most studied human genes. Its encoded protein, p53, is a tumor suppressor and is often called the "guardian of the genome" due to its pivotal role in maintaining genome stability. Historically, most studies of p53 have focused on its roles in somatic cells and tissues, but in the last 2 decades, its functions in embryonic stem cells (ESCs) and induced pluripotent stem cells have attracted increasing attention. Recent studies have identified p53 as a critical regulator of pluripotency, self-renewal, differentiation, proliferation, and genome stability in mouse and human embryonic stem cells. In this article, we systematically review the studies on the functions of p53 in ESCs, provide an updated overview, attempt to reconcile controversial results described in the literature, and discuss the relevance of these cellular functions of p53 to its roles in tumor suppression.

Indexed as

Genes, p53Tumor Suppressor Protein p53AnimalsCell DifferentiationEmbryonic Stem CellsGenomic InstabilityHumansMiceTP53 protein, humanTumor Suppressor Protein p53differentiationembryonic stem cellsgenomic stabilityp53self-renewaltumor suppressor

Identifiers

PMID35904997
PMCPMC9585900
OpenAlexW4288445906

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.